comparemela.com

BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD

BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

,Lourdes Felix ,Development Of Medications To ,End Addiction Initiative ,Agreement Terms ,National Survey On Drug ,Weight Loss Program ,Biocorrx Pharmaceuticals ,Crescendo Communications ,National Institutes Of Health ,Biocorrx Pharmaceuticals Inc ,Biocorrx Inc ,Over Three Years For Research ,National Institute On Drug Abuse ,Over Three Years ,Naltrexone Implant ,National Institute ,Drug Abuse ,National Institutes ,End Addiction Long Term Initiative ,Cooperative Agreement Terms ,Treat Opioid Use Disorders ,Clinical Trial Optional ,End Addiction Long Term ,National Survey ,Drug Use ,Addiction Recovery ,Cognitive Behavioral Therapy ,

comparemela.com © 2020. All Rights Reserved.